- Home
- CRESY vs BBNX Comparison
CRESY vs BBNX Comparison
Compare CRESY & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRESY
- BBNX
- Stock Information
- Founded
- CRESY 1936
- BBNX 2015
- Country
- CRESY Argentina
- BBNX United States
- Employees
- CRESY N/A
- BBNX N/A
- Industry
- CRESY Real Estate
- BBNX Medical/Dental Instruments
- Sector
- CRESY Finance
- BBNX Health Care
- Exchange
- CRESY Nasdaq
- BBNX Nasdaq
- Market Cap
- CRESY 664.8M
- BBNX 578.8M
- IPO Year
- CRESY 1997
- BBNX 2025
- Fundamental
- Price
- CRESY $11.66
- BBNX $15.20
- Analyst Decision
- CRESY
- BBNX Strong Buy
- Analyst Count
- CRESY 0
- BBNX 10
- Target Price
- CRESY N/A
- BBNX $24.40
- AVG Volume (30 Days)
- CRESY 155.7K
- BBNX 569.8K
- Earning Date
- CRESY 09-08-2025
- BBNX 07-29-2025
- Dividend Yield
- CRESY 5.01%
- BBNX N/A
- EPS Growth
- CRESY N/A
- BBNX N/A
- EPS
- CRESY 0.09
- BBNX N/A
- Revenue
- CRESY $648,198,954.00
- BBNX $69,830,000.00
- Revenue This Year
- CRESY N/A
- BBNX $32.71
- Revenue Next Year
- CRESY N/A
- BBNX $37.37
- P/E Ratio
- CRESY $11.23
- BBNX N/A
- Revenue Growth
- CRESY N/A
- BBNX 38911.17
- 52 Week Low
- CRESY $7.13
- BBNX $8.89
- 52 Week High
- CRESY $14.23
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- CRESY 56.88
- BBNX N/A
- Support Level
- CRESY $10.79
- BBNX N/A
- Resistance Level
- CRESY $11.58
- BBNX N/A
- Average True Range (ATR)
- CRESY 0.48
- BBNX 0.00
- MACD
- CRESY 0.04
- BBNX 0.00
- Stochastic Oscillator
- CRESY 67.88
- BBNX 0.00
About CRESY Cresud S.A.C.I.F. y A.
Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.